Antegrin Therapeutics company logo

Antegrin Therapeutics

antegrin.com

Total Raised

$700K

Investors Count

3

Funding, Valuation & Revenue

3 Fundings

Antegrin Therapeutics has raised $700K over 3 rounds.

Antegrin Therapeutics's latest funding round was a Merger for on October 17, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

10/17/2016

Merger

$XXM

0

FY undefined

3

10/2/2015

Seed VC

$XXM

$XXM

0

FY undefined

10

1/1/2015

Seed

$XXM

$XXM

0

FY undefined

10

Date

10/17/2016

10/2/2015

1/1/2015

Round

Merger

Seed VC

Seed

Amount

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

Start free trial
New call-to-action

Antegrin Therapeutics Investors

3 Investors

Antegrin Therapeutics has 3 investors. Indalo Therapeutics invested in Antegrin Therapeutics's Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/17/2016

10/17/2016

1
Merger

Corporation

Massachusetts

00/00/0000

00/00/0000

iSelect Fund

Subscribe to see more

Venture Capital

Missouri

00/00/0000

00/00/0000

BioGenerator

Subscribe to see more

Non-Profit Foundation

Missouri

First funding

10/17/2016

00/00/0000

00/00/0000

Last Funding

10/17/2016

00/00/0000

00/00/0000

Investor

iSelect Fund

BioGenerator

Rounds

1
Merger

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Venture Capital

Non-Profit Foundation

Location

Massachusetts

Missouri

Missouri

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.